ADORNATO, ILENIA
 Distribuzione geografica
Continente #
EU - Europa 489
NA - Nord America 383
AS - Asia 82
Totale 954
Nazione #
US - Stati Uniti d'America 380
IE - Irlanda 143
PL - Polonia 103
SE - Svezia 101
IT - Italia 94
CN - Cina 40
SG - Singapore 31
DE - Germania 11
FI - Finlandia 7
NL - Olanda 7
FR - Francia 6
BE - Belgio 5
IN - India 5
CA - Canada 3
GB - Regno Unito 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
VN - Vietnam 2
AL - Albania 1
AT - Austria 1
LT - Lituania 1
PK - Pakistan 1
RO - Romania 1
TR - Turchia 1
Totale 954
Città #
Dublin 143
Chandler 116
Warsaw 102
Nyköping 81
Messina 30
Ashburn 27
Dearborn 25
Singapore 24
Princeton 21
Medford 15
Beijing 14
Ann Arbor 13
Des Moines 11
San Mateo 9
Jacksonville 8
Munich 7
Haikou 6
Brussels 5
Francofonte 5
Rome 5
Amsterdam 4
Cagliari 4
Cambridge 4
Los Angeles 4
Boardman 3
Den Haag 3
Falls Church 3
Florence 3
Fontaniva 3
Guangzhou 3
Helsinki 3
Pune 3
Seattle 3
Serrastretta 3
Wilmington 3
Brno 2
Clearwater 2
Cosenza 2
Dong Ket 2
Fuzhou 2
Hyderabad 2
Jakarta 2
Jinan 2
Malfa 2
Nanjing 2
Ningbo 2
Palermo 2
Riva 2
Shenyang 2
Taizhou 2
Toronto 2
Washington 2
Aci Sant'antonio 1
Augusta 1
Brunico 1
Büdelsdorf 1
Changsha 1
Chengdu 1
Cupertino 1
Frankfurt am Main 1
Houston 1
Lanzhou 1
Lappeenranta 1
Montpellier 1
Montréal 1
Redwood City 1
Saint-denis 1
Saratov 1
Satriano 1
Siracusa 1
Southend 1
Stamford 1
Taiyuan 1
Tianjin 1
Tirana 1
Vienna 1
Totale 774
Nome #
Progettazione, sintesi e valutazione di nuove molecole attive come inibitori di enzimi coinvolti nello sviluppo del diabete mellito e delle sue complicazioni 181
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 76
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 66
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 64
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 56
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 52
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 52
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 51
null 50
Searching for alpha-syn inhibitors to fight Parkinson’s disease 50
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 49
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 45
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 44
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 44
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 35
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 34
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 29
null 13
null 12
Totale 1.003
Categoria #
all - tutte 4.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 0 9 28 21 15 6 17 9 7
2020/202184 9 6 12 2 12 3 5 2 20 4 5 4
2021/2022146 0 19 1 16 15 10 8 2 2 14 6 53
2022/2023405 27 69 23 30 13 41 21 7 161 0 8 5
2023/2024100 7 14 6 22 6 12 0 6 2 3 1 21
2024/202552 1 12 1 20 18 0 0 0 0 0 0 0
Totale 1.003